Tower Research Capital LLC (Trc) Medicinova Inc Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Medicinova Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,590 shares of MNOV stock, worth $15,249. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,590

Previous 8,137 30.15%

Holding current value

$15,249

Previous $12,000 25.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.28 - $1.65 $3,139 - $4,047	2,453 Added 30.15%	10,590 $15,000
Q4 2023 Feb 13, 2024	SELL	$1.38 - $2.06 $1,577 - $2,354	-1,143 Reduced 12.32%	8,137 $12,000
Q3 2023 Nov 14, 2023	BUY	$2.01 - $2.6 $1,340 - $1,734	667 Added 7.74%	9,280 $19,000
Q2 2023 Aug 14, 2023	SELL	$2.09 - $2.43 $24,904 - $28,955	-11,916 Reduced 58.04%	8,613 $19,000
Q1 2023 May 09, 2023	SELL	$1.95 - $2.54 $30,476 - $39,697	-15,629 Reduced 43.22%	20,529 $44,000

Q4 2022 Feb 10, 2023	BUY	$1.97 - $2.66 $62,647 - $84,590	31,801 Added 729.88%	36,158 $74,000
Q3 2022 Nov 10, 2022	SELL	$2.1 - $2.6 $7,654 - $9,477	-3,645 Reduced 45.55%	4,357 $10,000
Q2 2022 Aug 15, 2022	BUY	$2.31 - $3.14 $8,103 - $11,015	3,508 Added 78.06%	8,002 $20,000
Q1 2022 May 12, 2022	BUY	$2.19 - $2.81 $9,265 - $11,889	4,231 Added 1608.75%	4,494 $12,000
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.42 $15,106 - $25,582	-5,788 Reduced 95.65%	263 $1,000
Q3 2021 Nov 15, 2021	SELL	$3.4 - $4.24 $6,184 - $7,712	-1,819 Reduced 23.11%	6,051 $23,000
Q2 2021 Aug 16, 2021	BUY	$3.76 - $5.14 $14,220 - $19,439	3,782 Added 92.51%	7,870 $34,000
Q1 2021 May 17, 2021	SELL	$4.81 - $8.74 $33,164 - $60,262	-6,895 Reduced 62.78%	4,088 $21,000
Q4 2020 Feb 16, 2021	SELL	$5.03 - $6.31 $163,867 - $205,567	-32,578 Reduced 74.79%	10,983 $58,000
Q3 2020 Nov 16, 2020	BUY	$4.67 - $11.0 $154,180 - $363,165	33,015 Added 313.06%	43,561 $228,000
Q2 2020 Aug 13, 2020	BUY	$3.06 - $7.06 $32,270 - $74,454	10,546 New	10,546 $57,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.97 $176 - $425	-61 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$6.48 - $8.76 $35,685 - $48,241	-5,507 Reduced 98.9%	61 $0
Q3 2019 Nov 05, 2019	SELL	$7.7 - $10.42 $26,711 - $36,146	-3,469 Reduced 38.39%	5,568 $44,000
Q2 2019 Aug 13, 2019	BUY	$8.29 - $13.22 $31,377 - $50,037	3,785 Added 72.07%	9,037 $87,000
Q1 2019 May 14, 2019	BUY	$6.82 - $10.27 $6,356 - $9,571	932 Added 21.57%	5,252 $44,000
Q4 2018 Feb 14, 2019	BUY	$7.65 - $12.83 $32,566 - $54,617	4,257 Added 6757.14%	4,320 $36,000
Q3 2018 Nov 13, 2018	BUY	$7.06 - $12.49 $444 - $786	63 New	63 $1,000
Q2 2018 Aug 15, 2018	SELL	$7.96 - $13.23 $11,470 - $19,064	-1,441 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$6.6 - $13.91 $4,283 - $9,027	-649 Reduced 31.05%	1,441 $15,000
Q4 2017 Feb 09, 2018	SELL	$5.89 - $7.21 $9,270 - $11,348	-1,574 Reduced 42.96%	2,090 $14,000
Q3 2017 Nov 14, 2017	BUY	$4.43 - $6.58 $16,231 - $24,109	3,664	3,664 $23,000

Others Institutions Holding MNOV

# of Institutions

Shares Held

4.58M

Call Options Held

12.5K

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $70.6M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Medicinova Inc Transaction History